Exhibit No.
|
|
Description
|
Fiverr International Ltd.
|
|
Date: February 22, 2023
|
By: /s/ Ofer Katz
Ofer Katz
President and Chief Financial Officer
|
●
|
Cost reduction and efficient execution drove improvement in operating leverage: We continue to navigate
the challenging macro environment with strong execution and cost discipline, delivering Adjusted EBITDA ahead of the top end of our guidance and the highest quarterly Adjusted EBITDA in our history.
|
●
|
Total number of categories on Fiverr reached 600 with AI services being the newest addition: Category
expansion continues to be a key growth strategy, expanding our addressable market and driving traffic and conversion. AI-related services saw tremendous growth in the past few weeks as SMBs seek expert help to utilize the latest
technology.
|
●
|
Continued expansion of Promoted Gigs and Seller Plus: Promoted Gigs expands from listing pages to buyers’
inbox dashboard, providing buyers with seller recommendations that are directly relevant to their ongoing projects. Seller Plus, with the launch of a second tier pricing, reached over 10,000 active subscribers.
|
●
|
Committed to further improve Adjusted EBITDA in 2023: For 2023, we will build on the progress of 2022, to
deliver further headway towards our long-term Adjusted EBITDA margin target of 25%. While the macro continues to be highly uncertain, with discipline and control, we are committed to accelerate the pace of our Adjusted EBITDA margin
expansion this year.
|
●
|
Revenue in the fourth quarter of 2022 was $83.1 million, an increase of 4.2% year over year.
|
●
|
Active buyers1 as of December 31, 2022 grew to 4.3 million, compared to 4.2 million as of December 31, 2021, an increase of 1% year
over year.
|
●
|
Spend per buyer1 as of December 31, 2022 reached $262, compared to $242 as of December 31, 2021, an increase of 8% year over year.
|
●
|
Take rate1 for the period ended December 31, 2022 was 30.2%, up from 29.2% for the period ended December 31, 2021, an increase of 100
basis points year over year.
|
●
|
GAAP gross margin in the fourth quarter of 2022 was 81.0%, an increase of 10 basis points from 80.9% in the fourth quarter of 2021. Non-GAAP gross
margin1 in the fourth quarter of 2022 was 83.1%, a decrease of 30 basis points from 83.4% in the fourthquarter of 2021.
|
●
|
GAAP net loss in the fourth quarter of 2022 was ($1.3) million, or ($0.03) basic and diluted net loss per share, compared to ($19.5) million, or
($0.53) basic and diluted net loss per share, in the fourth quarter of 2021. Non-GAAP net income1 in the fourth quarter of 2022 was $10.7 million, or $0.29 basic non-GAAP net income per share1 and $0.26 diluted
non-GAAP net income per share1, compared to $0.25 basic non-GAAP net income per share1 and $0.22 diluted non-GAAP net income per share1, in the fourth quarter of 2021.
|
●
|
Adjusted EBITDA1 in the fourth quarter of 2022 was $9.4 million, compared to $8.9 million in
the fourth quarter of 2021. Adjusted EBITDA margin1 was 11.3% in the fourth quarter of 2022, compared to 11.1% in the fourth quarter of 2021.
|
●
|
Revenue in 2022 was $337.4 million, an increase of 13.3% year over year.
|
●
|
GAAP gross margin in 2022 was 80.5%, a decrease of 210 basis points from 82.6% in 2021. Non-GAAP gross margin1 in 2022 was 83.0%, a
decrease of 110 basis points from 84.1% in 2021.
|
●
|
GAAP net loss in 2022 was ($71.5) million, or ($1.94) net loss per share, compared to a net loss of ($65.0) million, or ($1.81) net loss per
share, in 2021. Non-GAAP net income1 in 2022 was $28.9 million, or $0.78 and $0.71 basic and diluted Non-GAAP net income per share1, respectively, compared to a $24.5 million, or $0.68 and $0.60 basic and diluted
Non-GAAP net income per share1, in 2021.
|
●
|
Adjusted EBITDA1 in 2022 was $24.4 million, compared to $22.9 million in 2021. Adjusted EBITDA margin1 was 7.2% in 2022, a
decrease of 50 basis points from 7.7% in 2021.
|
Q1 2023
|
FY 2023
|
|
Revenue
|
$86.5 - $88.5 million
|
$350.0 - $365.0 million
|
y/y growth
|
0% - 2% y/y growth
|
4% - 8% y/y growth
|
Adjusted EBITDA(1)
|
$9.0 - $10.5 million
|
$45.0 - $55.0 million
|
December 31,
|
December 31,
|
|||||||
2022
|
2021
|
|||||||
(Unaudited) | (Audited) | |||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash and cash equivalents
|
$
|
86,752
|
$
|
71,151
|
||||
Restricted cash
|
1,137
|
2,919
|
||||||
Marketable securities
|
241,293
|
118,150
|
||||||
User funds
|
143,020
|
127,713
|
||||||
Bank deposits
|
134,000
|
134,000
|
||||||
Other receivables
|
19,019
|
14,285
|
||||||
Total current assets
|
625,221
|
468,218
|
||||||
Marketable securities
|
189,839
|
317,524
|
||||||
Property and equipment, net
|
5,660
|
6,555
|
||||||
Operating lease right of use asset, net
|
9,077
|
11,727
|
||||||
Intangible assets, net
|
14,770
|
49,221
|
||||||
Goodwill
|
77,270
|
77,270
|
||||||
Other non-current assets
|
1,965
|
1,055
|
||||||
Total assets
|
$
|
923,802
|
$
|
931,570
|
||||
Liabilities and Shareholders' Equity
|
||||||||
Current liabilities:
|
||||||||
Trade payables
|
$
|
8,630
|
$
|
8,699
|
||||
User accounts
|
133,032
|
118,616
|
||||||
Deferred revenue
|
11,353
|
12,145
|
||||||
Other account payables and accrued expenses
|
41,328
|
44,260
|
||||||
Operating lease liabilities, net
|
2,755
|
3,055
|
||||||
Current maturities of long-term loan
|
-
|
2,269
|
||||||
Total current liabilities
|
197,098
|
189,044
|
||||||
Long-term liabilities:
|
||||||||
Convertible notes
|
452,764
|
372,076
|
||||||
Operating lease liabilities
|
6,649
|
10,483
|
||||||
Long-term loan and other non-current liabilities
|
1,559
|
13,099
|
||||||
Total long-term liabilities
|
460,972
|
395,658
|
||||||
Total liabilities
|
$
|
658,070
|
$
|
584,702
|
||||
Shareholders' equity:
|
||||||||
Share capital and additional paid-in capital
|
565,834
|
585,548
|
||||||
Accumulated deficit
|
(288,039
|
)
|
(237,585
|
)
|
||||
Accumulated other comprehensive income (loss)
|
(12,063
|
)
|
(1,095
|
)
|
||||
Total shareholders' equity
|
265,732
|
346,868
|
||||||
Total liabilities and shareholders' equity
|
$
|
923,802
|
$
|
931,570
|
Three Months Ended
|
Year Ended
|
|||||||||||||||
December 31,
|
December 31,
|
|||||||||||||||
|
2022
|
2021
|
2022
|
2021
|
||||||||||||
(Unaudited) | (Unaudited) | (Audited) | ||||||||||||||
Revenue
|
$
|
83,130
|
$
|
79,755
|
$
|
337,366
|
$
|
297,662
|
||||||||
Cost of revenue
|
15,814
|
15,213
|
65,948
|
51,723
|
||||||||||||
Gross profit
|
67,316
|
64,542
|
271,418
|
245,939
|
||||||||||||
Operating expenses:
|
||||||||||||||||
Research and development
|
21,328
|
21,829
|
92,563
|
79,298
|
||||||||||||
Sales and marketing
|
40,448
|
40,244
|
174,599
|
159,365
|
||||||||||||
General and administrative
|
7,762
|
16,345
|
51,161
|
52,616
|
||||||||||||
Impairment of intangible assets
|
-
|
-
|
27,629
|
-
|
||||||||||||
Total operating expenses
|
69,538
|
78,418
|
345,952
|
291,279
|
||||||||||||
Operating loss
|
(2,222
|
)
|
(13,876
|
)
|
(74,534
|
)
|
(45,340
|
)
|
||||||||
Financial income (expenses), net
|
1,391
|
(5,636
|
)
|
3,624
|
(19,513
|
)
|
||||||||||
Loss before income taxes
|
(831
|
)
|
(19,512
|
)
|
(70,910
|
)
|
(64,853
|
)
|
||||||||
Income taxes
|
(468
|
)
|
(8
|
)
|
(577
|
)
|
(159
|
)
|
||||||||
Net loss attributable to ordinary shareholders
|
$
|
(1,299
|
)
|
$
|
(19,520
|
)
|
$
|
(71,487
|
)
|
$
|
(65,012
|
)
|
||||
Basic and diluted net loss per share attributable to ordinary shareholders
|
$
|
(0.03
|
)
|
$
|
(0.53
|
)
|
$
|
(1.94
|
)
|
$
|
(1.81
|
)
|
||||
Basic and diluted weighted average ordinary shares
|
37,411,657
|
36,666,637
|
36,856,140
|
35,955,014
|
Three Months Ended
|
Twelve Months Ended
|
|||||||||||||||
December 31,
|
December 31,
|
|||||||||||||||
2022
|
2021
|
2022
|
2021
|
|||||||||||||
(Unaudited) |
(Unaudited) | (Audited) | ||||||||||||||
Operating Activities
|
||||||||||||||||
Net loss
|
$
|
(1,299
|
)
|
$
|
(19,520
|
)
|
$
|
(71,487
|
)
|
$
|
(65,012
|
)
|
||||
Adjustments to reconcile net loss to net cash provided by operating activities:
|
||||||||||||||||
Depreciation and amortization
|
1,995
|
2,772
|
10,185
|
6,876
|
||||||||||||
Loss from disposal of property and equipment
|
(5
|
)
|
19
|
(26
|
)
|
(13
|
)
|
|||||||||
Amortization of premium and discount of marketable securities, net
|
1,333
|
2,287
|
6,385
|
7,903
|
||||||||||||
Amortization of discount and issuance costs of convertible notes
|
633
|
5,112
|
2,527
|
20,029
|
||||||||||||
Shared-based compensation
|
17,026
|
16,646
|
71,755
|
55,407
|
||||||||||||
Net loss (Gain) from exchange rate fluctuations
|
(152
|
)
|
(86
|
)
|
31
|
242
|
||||||||||
Impairment of intangible assets
|
-
|
-
|
27,629
|
-
|
||||||||||||
Changes in assets and liabilities:
|
||||||||||||||||
User funds
|
2,277
|
(967
|
)
|
(15,307
|
)
|
(29,729
|
)
|
|||||||||
Operating lease ROU assets and liabilities, net
|
62
|
424
|
(1,485
|
)
|
253
|
|||||||||||
Other receivables
|
(10
|
)
|
(3,909
|
)
|
(4,847
|
)
|
(6,240
|
)
|
||||||||
Trade payables
|
2,771
|
4,052
|
(113
|
)
|
4,667
|
|||||||||||
Deferred revenue
|
(263
|
)
|
990
|
(792
|
)
|
4,123
|
||||||||||
User accounts
|
(1,933
|
)
|
445
|
14,416
|
26,589
|
|||||||||||
Account payable, accrued expenses and other non-current liabilities
|
(5,368
|
)
|
600
|
3,994
|
1,678
|
|||||||||||
Revaluation of contingent consideration
|
(7,462
|
)
|
(620
|
)
|
(12,249
|
)
|
11,771
|
|||||||||
Payment of contingent consideration
|
-
|
-
|
(504
|
)
|
(507
|
)
|
||||||||||
Net cash provided by operating activities
|
9,605
|
8,245
|
30,112
|
38,037
|
||||||||||||
Investing Activities
|
||||||||||||||||
Investment in marketable securities
|
(51,694
|
)
|
(46,512
|
)
|
(141,701
|
)
|
(282,450
|
)
|
||||||||
Proceeds from sale of marketable securities
|
13,180
|
49,437
|
130,701
|
193,757
|
||||||||||||
Bank and restricted deposits
|
(37,863
|
)
|
2,885
|
-
|
(41,115
|
)
|
||||||||||
Acquisition of business, net of cash acquired
|
-
|
(87,796
|
)
|
-
|
(97,084
|
)
|
||||||||||
Acquisition of intangible asset
|
-
|
-
|
(175
|
)
|
-
|
|||||||||||
Purchase of property and equipment
|
(87
|
)
|
(330
|
)
|
(1,198
|
)
|
(1,684
|
)
|
||||||||
Capitalization of internal-use software and other
|
19
|
(322
|
)
|
(1,000
|
)
|
(894
|
)
|
|||||||||
Other non-current assets
|
(73
|
)
|
-
|
(1,251
|
)
|
-
|
||||||||||
Net cash used in investing activities
|
(76,518
|
)
|
(82,638
|
)
|
(14,624
|
)
|
(229,470
|
)
|
||||||||
Financing Activities
|
||||||||||||||||
Payment of convertible notes deferred issuance costs
|
-
|
-
|
-
|
(34
|
)
|
|||||||||||
Deferred issuance cost
|
-
|
381
|
-
|
-
|
||||||||||||
Payment of contingent consideration
|
-
|
-
|
(1,105
|
)
|
(1,105
|
)
|
||||||||||
Proceeds from exercise of share options
|
1,457
|
1,028
|
3,765
|
8,294
|
||||||||||||
Tax withholding in connection with employees' options exercises and vested RSUs
|
258
|
1,374
|
(2,028
|
)
|
(8,987
|
)
|
||||||||||
Repayment of long-term loan
|
-
|
(149
|
)
|
(2,269
|
)
|
(565
|
)
|
|||||||||
Net cash provided by (used in) financing activities
|
1,715
|
2,634
|
(1,637
|
)
|
(2,397
|
)
|
||||||||||
Effect of exchange rate fluctuations on cash and cash equivalents
|
151
|
188
|
(32
|
)
|
(130
|
)
|
||||||||||
Increase (decrease) in cash, cash equivalents and restricted cash
|
(65,047
|
)
|
(71,571
|
)
|
13,819
|
(193,960
|
)
|
|||||||||
Cash, cash equivalents and restricted cash at the beginning of period
|
152,936
|
145,641
|
74,070
|
268,030
|
||||||||||||
Cash, cash equivalents and restricted cash at the end of period
|
$
|
87,889
|
$
|
74,070
|
$
|
87,889
|
$
|
74,070
|
Twelve Months Ended
December 31,
|
||||||||
2022
|
2021
|
|||||||
Annual active buyers (in thousands)
|
4,275
|
4,217
|
||||||
Annual spend per buyer ($)
|
$
|
262
|
$
|
242
|
Three Months Ended
|
Year Ended
|
|||||||||||||||
December 31,
|
December 31,
|
|||||||||||||||
|
2022
|
2021
|
2022
|
2021
|
||||||||||||
(Unaudited) |
(Unaudited) | |||||||||||||||
GAAP gross profit
|
$
|
67,316
|
$
|
64,542
|
$
|
271,418
|
$
|
245,939
|
||||||||
Add:
|
||||||||||||||||
Share-based compensation and other
|
565
|
447
|
2,520
|
1,436
|
||||||||||||
Depreciation and amortization
|
1,170
|
1,548
|
6,065
|
2,879
|
||||||||||||
Non-GAAP gross profit
|
$
|
69,051
|
$
|
66,537
|
$
|
280,003
|
$
|
250,254
|
||||||||
Non-GAAP gross margin
|
83.1
|
%
|
83.4
|
%
|
83.0
|
%
|
84.1
|
%
|
Three Months Ended
|
Year Ended
|
|||||||||||||||
December 31,
|
December 31,
|
|||||||||||||||
|
2022
|
2021
|
2022
|
2021
|
||||||||||||
(Unaudited) |
(Unaudited) |
|||||||||||||||
GAAP net loss attributable to ordinary shareholders
|
$
|
(1,299
|
)
|
$
|
(19,520
|
)
|
$
|
(71,487
|
)
|
$
|
(65,012
|
)
|
||||
Add:
|
||||||||||||||||
Depreciation and amortization
|
$
|
1,995
|
$
|
2,772
|
$
|
10,185
|
$
|
6,876
|
||||||||
Share-based compensation
|
17,026
|
16,646
|
71,755
|
55,407
|
||||||||||||
Impairment of intangible assets
|
-
|
-
|
27,629
|
-
|
||||||||||||
Contingent consideration revaluation, acquisition related costs and other
|
(7,403
|
)
|
3,338
|
(10,613
|
)
|
5,914
|
||||||||||
Convertible notes amortization of discount and issuance costs
|
633
|
5,112
|
2,527
|
20,029
|
||||||||||||
Exchange rate (gain)/loss, net
|
(209
|
)
|
896
|
(1,141
|
)
|
1,273
|
||||||||||
Non-GAAP net income
|
$
|
10,743
|
$
|
9,244
|
$
|
28,855
|
$
|
24,487
|
||||||||
Weighted average number of ordinary shares - basic
|
37,411,657
|
36,666,637
|
36,856,140
|
35,955,014
|
||||||||||||
Non-GAAP basic net income per share attributable to ordinary shareholders
|
$
|
0.29
|
$
|
0.25
|
$
|
0.78
|
$
|
0.68
|
||||||||
Weighted average number of ordinary shares - diluted
|
40,783,489
|
41,231,973
|
40,662,057
|
40,883,007
|
||||||||||||
Non-GAAP diluted net income per share attributable to ordinary shareholders
|
$ | 0.26 | $ | 0.22 | $ | 0.71 | $ | 0.60 |
Three Months Ended
|
Year Ended
|
|||||||||||||||
December 31,
|
December 31,
|
|||||||||||||||
|
2022
|
2021
|
2022
|
2021
|
||||||||||||
(Unaudited) |
(Unaudited) | |||||||||||||||
GAAP net loss
|
$
|
(1,299
|
)
|
$
|
(19,520
|
)
|
$
|
(71,487
|
)
|
$
|
(65,012
|
)
|
||||
Add:
|
||||||||||||||||
Financial (income) expenses, net
|
$
|
(1,391
|
)
|
$
|
5,636
|
$
|
(3,624
|
)
|
$
|
19,513
|
||||||
Income taxes
|
468
|
8
|
577
|
159
|
||||||||||||
Depreciation and amortization
|
1,995
|
2,772
|
10,185
|
6,876
|
||||||||||||
Share-based compensation
|
17,026
|
16,646
|
71,755
|
55,407
|
||||||||||||
Impairment of intangible assets
|
-
|
-
|
27,629
|
-
|
||||||||||||
Contingent consideration revaluation, acquisition related costs and other
|
(7,403
|
)
|
3,338
|
(10,613
|
)
|
5,914
|
||||||||||
Adjusted EBITDA
|
$
|
9,396
|
$
|
8,880
|
$
|
24,422
|
$
|
22,857
|
||||||||
Adjusted EBITDA margin
|
11.3
|
%
|
11.1
|
%
|
7.2
|
%
|
7.7
|
%
|
Three Months Ended
|
Year Ended
|
|||||||||||||||
December 31,
|
December 31,
|
|||||||||||||||
|
2022
|
2021
|
2022
|
2021
|
||||||||||||
(Unaudited) |
(Unaudited) |
|||||||||||||||
GAAP research and development
|
$
|
21,328
|
21,829
|
$
|
92,563
|
79,298
|
||||||||||
Less:
|
||||||||||||||||
Share-based compensation
|
5,291
|
5,750
|
23,828
|
20,008
|
||||||||||||
Depreciation and amortization
|
198
|
204
|
801
|
786
|
||||||||||||
Non-GAAP research and development
|
$
|
15,839
|
$
|
15,875
|
$
|
67,934
|
$
|
58,504
|
||||||||
GAAP sales and marketing
|
$
|
40,448
|
$
|
40,244
|
$
|
174,599
|
$
|
159,365
|
||||||||
Less:
|
||||||||||||||||
Share-based compensation
|
4,040
|
4,296
|
17,196
|
14,106
|
||||||||||||
Depreciation and amortization
|
495
|
957
|
2,889
|
2,977
|
||||||||||||
Contingent consideration revaluation, acquisition related costs and other
|
(24
|
)
|
402
|
(24
|
)
|
1,499
|
||||||||||
Non-GAAP sales and marketing
|
$
|
35,937
|
$
|
34,589
|
$
|
154,538
|
$
|
140,783
|
||||||||
GAAP general and administrative
|
$
|
7,762
|
$
|
16,345
|
$
|
51,161
|
$
|
52,616
|
||||||||
Less:
|
||||||||||||||||
Share-based compensation
|
7,130
|
6,153
|
28,211
|
19,857
|
||||||||||||
Depreciation and amortization
|
132
|
63
|
430
|
234
|
||||||||||||
Contingent consideration revaluation, acquisition related costs and other
|
(7,379
|
)
|
2,936
|
(10,589
|
)
|
4,415
|
||||||||||
Non-GAAP general and administrative
|
$
|
7,879
|
$
|
7,193
|
$
|
33,109
|
$
|
28,110
|